TickerFactsScreenerDevelopers

Arcutis Biotherapeutics, Inc. (ARQT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$14.09M2019: -$42.84M2020: -$113.03M2021: -$174.63M2022: -$257.71M2023: -$247.06M2024: -$112.16M2025: -$5.62M-$5.62M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$5.62M+95.0%
2024-$112.16M+54.6%
2023-$247.06M+4.1%
2022-$257.71M-47.6%
2021-$174.63M-54.5%
2020-$113.03M-163.9%
2019-$42.84M-204.1%
2018-$14.09M—